Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
Hussain
W
W
Coulson
I
I
Owen
C
C
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D009260:Nail Diseases / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D011788:Quality of Life / Q000523:psychology*; D012008:Recurrence; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab